Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma

Bone Marrow Transplant. 2011 May;46(5):764-5. doi: 10.1038/bmt.2010.180. Epub 2010 Aug 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Boronic Acids / administration & dosage*
  • Bortezomib
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Melphalan / administration & dosage*
  • Melphalan / therapeutic use
  • Middle Aged
  • Multiple Myeloma / surgery*
  • Pyrazines / administration & dosage*
  • Recurrence
  • Retrospective Studies
  • Transplantation Conditioning / methods*
  • Transplantation, Autologous

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Melphalan